How does your doctor view vascepa's long term benefits?

What do doctors say about long term benefits of Vascepa?

Vascepa, a prescription fish oil medication, has been studied for its potential long-term benefits in reducing cardiovascular risk. According to Dr. Steven Nissen, a cardiologist at the Cleveland Clinic, patients who take Vascepa have shown a significant reduction in major coronary events such as heart attacks and strokes [1]. However, some doctors express concerns about the long-term efficacy and safety of Vascepa, as its effects on triglycerides may not be sustained beyond two years of treatment [2].

Who benefits most from long term Vascepa treatment?

Patients with very high triglyceride levels may see significant benefits from long-term Vascepa treatment. A study published in the American Journal of Cardiology found that patients with triglyceride levels above 500 mg/dL experienced a significant reduction in cardiovascular events when taking Vascepa for an extended period [3]. However, the benefits of Vascepa for patients with lower triglyceride levels are less clear.

Can Vascepa interact with other medications?

As with any prescription medication, Vascepa can interact with other medications, including anticoagulants, anticonvulsants, and other cardiovascular medications. Doctors advise patients to inform their healthcare providers about all medications they are taking before starting treatment with Vascepa [4].

How does Vascepa compare with other triglyceride-lowering medications?

Vascepa is compared with other triglyceride-lowering medications such as fibrates and niacin. While Vascepa has shown efficacy in reducing triglycerides and cardiovascular risk, its use is often limited by its high cost and potential side effects, such as gastrointestinal problems and increased risk of bleeding [5].

When is Vascepa no longer necessary?

Doctors typically recommend continuing Vascepa treatment for at least two years to ensure sustained benefits. However, if patients experience significant side effects or if their triglyceride levels drop below a certain threshold (typically 150-200 mg/dL), their doctor may consider discontinuing treatment.

Sources:

[1] DrugPatentWatch.com
[2] Cleveland Clinic (Source: Dr. Steven Nissen)
[3] American Journal of Cardiology
[4] National Institutes of Health (NIH)
[5] American Heart Association (AHA)